﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Shahrekord University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Shahrekord University of Medical Sciences</JournalTitle>
      <Issn>2717-0071</Issn>
      <Volume>28</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>07</Month>
        <DAY>29</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Antioxidative Effects of Umbelliprenin Against Acrylamide-Induced Hepatotoxicity in Mice</ArticleTitle>
    <FirstPage>98</FirstPage>
    <LastPage>103</LastPage>
    <ELocationID EIdType="doi">10.34172/jsums.1154</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Firoozeh</FirstName>
        <LastName>Saghaei</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-7997-6190</Identifier>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Karimi-Dehkordi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6086-2014</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jsums.1154</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>05</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>05</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Acrylamide (ACR) is a well-known hepatotoxicant commonly found in heat-processed carbohydrate-rich foods, which induces oxidative stress (OS) and liver injury in animal models. Umbelliprenin, a prenyloxy coumarin with documented antioxidant and anti-inflammatory properties, has been proposed as a potential hepatoprotective agent. This experimental study investigated the protective effects of umbelliprenin against ACR-induced hepatotoxicity in adult male albino mice.  Methods: Animals were randomly allocated to experimental groups. Mice were divided into control, ACR (50 mg/kg/day, oral), umbelliprenin (12.5 mg/kg/day, i.p.), ACR + umbelliprenin, and paraffin vehicle groups (n = 7 per). After 10 days of treatment, serum liver function enzymes (alanine aminotransferase [ALT], aspartate transferase [AST], alkaline phosphatase [ALP], and bilirubin) and OS markers, including malondialdehyde (MDA), total antioxidant capacity (TAC), and glutathione peroxidase (GPx) activity, underwent evaluation. Data were analyzed using SPSS version 26.0.  Results: ACR significantly increased ALT (P = 0.012), AST (P = 0.008), ALP (P = 0.003), bilirubin (P = 0.041), and MDA (P = 0.018) while decreasing TAC (P = 0.027) and GPx activity (P = 0.021), indicating hepatic oxidative damage. Based on the results, umbelliprenin co-administration mitigated these alterations, restoring ALT (vs. ACR group, P = 0.035) and bilirubin (P = 0.048) to near control levels, reducing MDA (P = 0.039), and partially improving TAC (P = 0.044) and GPx activities (P = 0.042).  Conclusion: Umbelliprenin exerts hepatoprotective effects against ACR-induced liver injury by enhancing antioxidant defenses, decreasing lipid peroxidation, and preserving liver function, emphasizing its potential as a natural therapeutic factor for chemically induced hepatotoxicity.  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Acrylamide</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Umbelliprenin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hepatotoxicity</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Oxidative stress</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mice</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>